121 related articles for article (PubMed ID: 16230389)
1. Down-regulation of integrin alpha2 surface expression by mutant epidermal growth factor receptor (EGFRvIII) induces aberrant cell spreading and focal adhesion formation.
Ning Y; Zeineldin R; Liu Y; Rosenberg M; Stack MS; Hudson LG
Cancer Res; 2005 Oct; 65(20):9280-6. PubMed ID: 16230389
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal transformation in epithelial ovarian tumor cells expressing epidermal growth factor receptor variant III.
Zeineldin R; Rosenberg M; Ortega D; Buhr C; Chavez MG; Stack MS; Kusewitt DF; Hudson LG
Mol Carcinog; 2006 Nov; 45(11):851-60. PubMed ID: 16788982
[TBL] [Abstract][Full Text] [Related]
3. Mutant epidermal growth factor receptor in benign, borderline, and malignant ovarian tumors.
Steffensen KD; Waldstrøm M; Olsen DA; Corydon T; Lorentzen KA; Knudsen HJ; Jeppesen U; Brandslund I; Jakobsen A
Clin Cancer Res; 2008 Jun; 14(11):3278-82. PubMed ID: 18519753
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME
Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460
[TBL] [Abstract][Full Text] [Related]
5. Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells.
Ramnarain DB; Park S; Lee DY; Hatanpaa KJ; Scoggin SO; Otu H; Libermann TA; Raisanen JM; Ashfaq R; Wong ET; Wu J; Elliott R; Habib AA
Cancer Res; 2006 Jan; 66(2):867-74. PubMed ID: 16424019
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the type III epidermal growth factor receptor variant mutant receptor by dominant-negative EGFR-CD533 enhances malignant glioma cell radiosensitivity.
Lammering G; Hewit TH; Holmes M; Valerie K; Hawkins W; Lin PS; Mikkelsen RB; Schmidt-Ullrich RK
Clin Cancer Res; 2004 Oct; 10(19):6732-43. PubMed ID: 15475464
[TBL] [Abstract][Full Text] [Related]
7. Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting.
Sok JC; Coppelli FM; Thomas SM; Lango MN; Xi S; Hunt JL; Freilino ML; Graner MW; Wikstrand CJ; Bigner DD; Gooding WE; Furnari FB; Grandis JR
Clin Cancer Res; 2006 Sep; 12(17):5064-73. PubMed ID: 16951222
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the epidermal growth factor receptor specific transcriptome: effect of receptor expression level and an activating mutation.
Pedersen MW; Pedersen N; Damstrup L; Villingshøj M; Sønder SU; Rieneck K; Bovin LF; Spang-Thomsen M; Poulsen HS
J Cell Biochem; 2005 Oct; 96(2):412-27. PubMed ID: 16075456
[TBL] [Abstract][Full Text] [Related]
9. Integrin alphavbeta3 mediates upregulation of epidermal growth-factor receptor expression and activity in human ovarian cancer cells.
Lössner D; Abou-Ajram C; Benge A; Reuning U
Int J Biochem Cell Biol; 2008; 40(12):2746-61. PubMed ID: 18577466
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression.
Micallef J; Taccone M; Mukherjee J; Croul S; Busby J; Moran MF; Guha A
Cancer Res; 2009 Oct; 69(19):7548-56. PubMed ID: 19773446
[TBL] [Abstract][Full Text] [Related]
11. Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapy.
Blehm KN; Spiess PE; Bondaruk JE; Dujka ME; Villares GJ; Zhao YJ; Bogler O; Aldape KD; Grossman HB; Adam L; McConkey DJ; Czerniak BA; Dinney CP; Bar-Eli M
Clin Cancer Res; 2006 Aug; 12(15):4671-7. PubMed ID: 16899617
[TBL] [Abstract][Full Text] [Related]
12. Integrin alpha2beta1 modulates EGF stimulation of Rho GTPase-dependent morphological changes in adherent human rhabdomyosarcoma RD cells.
Leabu M; Uniyal S; Xie J; Xu YQ; Vladau C; Morris VL; Chan BM
J Cell Physiol; 2005 Mar; 202(3):754-66. PubMed ID: 15481063
[TBL] [Abstract][Full Text] [Related]
13. Loss of collapsin response mediator Protein1, as detected by iTRAQ analysis, promotes invasion of human gliomas expressing mutant EGFRvIII.
Mukherjee J; DeSouza LV; Micallef J; Karim Z; Croul S; Siu KW; Guha A
Cancer Res; 2009 Nov; 69(22):8545-54. PubMed ID: 19903856
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor-induced ovarian carcinoma cell migration is associated with JAK2/STAT3 signals and changes in the abundance and localization of alpha6beta1 integrin.
Colomiere M; Findlay J; Ackland L; Ahmed N
Int J Biochem Cell Biol; 2009 May; 41(5):1034-45. PubMed ID: 18930836
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody cetuximab binds to and down-regulates constitutively activated epidermal growth factor receptor vIII on the cell surface.
Patel D; Lahiji A; Patel S; Franklin M; Jimenez X; Hicklin DJ; Kang X
Anticancer Res; 2007; 27(5A):3355-66. PubMed ID: 17970081
[TBL] [Abstract][Full Text] [Related]
16. Alterations in the expression of androgen receptor, wild type-epidermal growth factor receptor and a mutant epidermal growth factor receptor in human prostate cancer.
Olapade-Olaopa EO; Moscatello DK; MacKay EH; Sandhu DP; Terry TR; Wong AJ; Habib FK
Afr J Med Med Sci; 2004 Sep; 33(3):245-53. PubMed ID: 15819472
[TBL] [Abstract][Full Text] [Related]
17. Profile of differentially expressed genes mediated by the type III epidermal growth factor receptor mutation expressed in a small-cell lung cancer cell line.
Pedersen MW; Thykjaer T; Ørntoft TF; Damstrup L; Poulsen HS
Br J Cancer; 2001 Oct; 85(8):1211-8. PubMed ID: 11710837
[TBL] [Abstract][Full Text] [Related]
18. Expression of Epidermal Growth Factor Receptor variant III in laryngeal carcinoma tissues.
Yang B; Chen J; Zhang X; Cao J
Auris Nasus Larynx; 2009 Dec; 36(6):682-7. PubMed ID: 19427146
[TBL] [Abstract][Full Text] [Related]
19. Focal adhesion and actin organization by a cross-talk of TM4SF5 with integrin alpha2 are regulated by serum treatment.
Lee SY; Kim YT; Lee MS; Kim YB; Chung E; Kim S; Lee JW
Exp Cell Res; 2006 Oct; 312(16):2983-99. PubMed ID: 16828471
[TBL] [Abstract][Full Text] [Related]
20. EGF-stimulated migration in ovarian cancer cells is associated with decreased internalization, increased surface expression, and increased shedding of the urokinase plasminogen activator receptor.
Henic E; Sixt M; Hansson S; Høyer-Hansen G; Casslén B
Gynecol Oncol; 2006 Apr; 101(1):28-39. PubMed ID: 16263158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
